Buy One Get One free -Llimited Time Offer X
Kofarest Plus, a prescription drug, is manufactured in various forms such as Syrup. It is primarily used for the treatment of Common Cold, Cough, Bronchitis. Kofarest Plus also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Kofarest Plus. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The most common side effects of Kofarest Plus are Constipation, Heartburn. Besides the aforementioned side effects, there are other adverse effects of Kofarest Plus as well, which are listed below. Such side effects of Kofarest Plus normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Kofarest Plus has a Safe effect for pregnant women and Mild effect on lactating mothers. Warnings related to Kofarest Plus's effects on the liver, heart and kidney, if any, have been listed below.
Kofarest Plus is contraindicated in people with pre-existing medical conditions like Heart Disease, Asthma, Smoking Addiction as it can result in adverse effects. Other conditions have been mentioned below in the Kofarest Plus contraindications section.
Besides this, Kofarest Plus may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Kofarest Plus is considered not safe while driving, and is not addictive.
Kofarest Plus is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Kofarest Plus safe for pregnant women?
Kofarest Plus is safe to take during pregnancy.
Is the use of Kofarest Plus safe during breastfeeding?
Breastfeeding women can take Kofarest Plus as it bears very minor side effects for them.
What is the effect of Kofarest Plus on the Kidneys?
Very few cases of side effects of Kofarest Plus on kidney have been reported.
What is the effect of Kofarest Plus on the Liver?
Using Kofarest Plus does not have any harmful effects on the liver.
What is the effect of Kofarest Plus on the Heart?
There are no any side effects of Kofarest Plus for the heart.
Kofarest Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Kofarest Plus unless your doctor advises you to do so -
Is this Kofarest Plus habit forming or addictive?
Kofarest Plus is not addictive in nature.
Interaction between Food and Kofarest Plus
Taking Kofarest Plus with food does not cause any problems.
Interaction between Alcohol and Kofarest Plus
Taking Kofarest Plus with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vazculep (phenylephrine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 135-136
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1020-1022
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167